- Home
- PLUG vs COLL Comparison
PLUG vs COLL Comparison
Compare PLUG & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUG
- COLL
- Stock Information
- Founded
- PLUG 1997
- COLL 2002
- Country
- PLUG United States
- COLL United States
- Employees
- PLUG N/A
- COLL N/A
- Industry
- PLUG Industrial Machinery/Components
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- PLUG Energy
- COLL Health Care
- Exchange
- PLUG Nasdaq
- COLL Nasdaq
- Market Cap
- PLUG 1.0B
- COLL 864.7M
- IPO Year
- PLUG 1999
- COLL 2015
- Fundamental
- Price
- PLUG $0.86
- COLL $28.89
- Analyst Decision
- PLUG Hold
- COLL Strong Buy
- Analyst Count
- PLUG 17
- COLL 5
- Target Price
- PLUG $2.19
- COLL $43.80
- AVG Volume (30 Days)
- PLUG 109.5M
- COLL 343.0K
- Earning Date
- PLUG 05-12-2025
- COLL 05-08-2025
- Dividend Yield
- PLUG N/A
- COLL N/A
- EPS Growth
- PLUG N/A
- COLL N/A
- EPS
- PLUG N/A
- COLL 1.25
- Revenue
- PLUG $628,814,000.00
- COLL $664,283,000.00
- Revenue This Year
- PLUG $26.39
- COLL $19.96
- Revenue Next Year
- PLUG $25.44
- COLL $3.93
- P/E Ratio
- PLUG N/A
- COLL $23.07
- Revenue Growth
- PLUG N/A
- COLL 17.17
- 52 Week Low
- PLUG $0.76
- COLL $23.23
- 52 Week High
- PLUG $4.90
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- PLUG 39.64
- COLL 59.59
- Support Level
- PLUG $0.76
- COLL $26.72
- Resistance Level
- PLUG $1.19
- COLL $27.70
- Average True Range (ATR)
- PLUG 0.08
- COLL 1.02
- MACD
- PLUG 0.02
- COLL 0.24
- Stochastic Oscillator
- PLUG 23.37
- COLL 79.71
About PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.